Treatment Goals for LDL-c to Reduce Cardiovascular Risk Depending on CV Risk Estimation*
Treatment algorithm for pharmacological low-density lipoprotein cholesterol lowering*
Adapted from: 2019 ESC/EAS Guidelines for the management of dyslipidaemia: lipid modification to reduce cardiovascular risk. Eur Heart J 2020 Jan 1;41(1):111-188.
SCORE2 and SCORE2-OP Cardiovascular disease risk estimation stratified by age*
CV risk estimation |
< 50y |
50-69y |
> 70y |
Low / moderate |
< 2.5% |
< 5% |
< 7.5% |
High |
2.5-<7.5% |
5-<10% |
7.5-<15% |
Very high |
> 7.5% |
> 10% |
> 15% |
* For the cardiovascular risk definitions, please refer to the 2019 ESC/EAS Guidelines for the management of dyslipidaemia: lipid modification to reduce cardiovascular risk.